COMMUNIQUÉS West-GlobeNewswire

Shire plc : Rule 2.9 Announcement
26/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 26 June 2018 Shire [...]
IBT plans to start its phase 3 study in the second half of 2018 and contracts CRO
26/06/2018
IBT has previously announced its plan to start the phase 3 study in the first half of 2018. Preparations for the study have taken slightly longer than expected and the Company now plans to initiate the phase 3 study in [...]
FIT Biotech Oy: EHVA clinical trial authorization granted for testing FIT-06 in UK
26/06/2018
FIT Biotech Oy Company release 26.6.2018 at 8:30 AM EET EHVA clinical trial authorization granted for testing FIT-06 in UK FIT Biotech Oy ("Company", FITBIO: FN Finland) today announced that the UK medical authorities [...]
Novartis Clear about Psoriasis survey data highlights challenges psoriasis patients face to achieve goal of clear skin
26/06/2018
Survey data published in JEADV show that patients experienced four different treatments and three medical professionals on average before finding an efficacious therapy[1] New publication also highlights that over 50% [...]
Basilea starts clinical phase 2a expansion with BAL101553 in ovarian cancer and glioblastoma
26/06/2018
Basel, Switzerland, June 26, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the first patient has been dosed in the phase 2a expansion part of Basilea's ongoing phase 1/2a clinical study with its [...]
Fagron NV: Disclosure of received notifications
26/06/2018
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 26 June 2018 - 6:30am (CET) Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron [...]
Immuron Announces Board Appointment
26/06/2018
MELBOURNE, Australia, June 25, 2018 (GLOBE NEWSWIRE) -- Australian biopharmaceutical company Immuron Limited (ASX:IMC), is pleased to announce the appointment of New York based Mr. Richard Jay Berman to serve as a [...]
Zomedica Joins Russell 3000™ and Russell Microcap® Indexes
25/06/2018
ANN ARBOR, Mich., June 25, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical company, today announced that [...]
Wave Life Sciences to Present at Parent Project Muscular Dystrophy Annual Conference
25/06/2018
CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases [...]
UPDATE: Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
25/06/2018
ARLINGTON, Va., June 25, 2018 (GLOBE NEWSWIRE) -- Today IMV, part of the Science and Medicine Group, and the leading market research and business intelligence provider to the Imaging industry, announced the category [...]
Real-World Data Supports Association Between High Triglyceride Levels and Increased Cardiovascular Events and Healthcare Costs in People with Diabetes Mellitus
25/06/2018
Data Underscores the Need for the REDUCE-IT™ Cardiovascular Outcomes Study BEDMINSTER, N.J. and DUBLIN, Ireland, June 25, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company [...]
AVROBIO, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Overallotment Option
25/06/2018
CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc . (NASDAQ:AVRO) (the “Company”), a Phase 2 clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based gene [...]
Eloxx Expands Leadership Team with Two Global Pharmaceutical Executives to Accelerate Growth
25/06/2018
Dr. Greg Williams appointed Chief Operating Officer David P. Snow appointed Chief Business Officer Eloxx added to the Russell 2000® Index effective June 25, 2018 WALTHAM, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Eloxx [...]
Actinium Provides Update from Society of Nuclear Medicine and Molecular Imaging Annual Meeting
25/06/2018
Two Nuclear Medicine focused advisory boards have been formed to provide expertise and strategic guidance to Actinium Meeting with Iomab-B and Actimab investigators to be held to provide trial updates and discuss [...]
Sunesis Pharmaceuticals Enters into $15.5 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
25/06/2018
SOUTH SAN FRANCISCO, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it has entered into a Common Shares Purchase Agreement (the “Agreement”) of up to $15.5 [...]
Prothena Announces Appointment of Tran B. Nguyen as Chief Operating Officer
25/06/2018
DUBLIN, Ireland, June 25, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage biotechnology company focused on the discovery and development of novel therapies in the neuroscience category [...]
Opiant Pharmaceuticals Announces Receipt of First Tranche from National Institutes of Health Grant for Development of OPNT003, Intranasal Nalmefene, for Treatment of Opioid Overdose
25/06/2018
Initial $500,000 to be Utilized to Advance the Development of OPNT003 SANTA MONICA, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company [...]
NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock
25/06/2018
Closes on $30 Million Extension to Senior Credit Facility FT. MYERS, Fla., June 25, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ:NEO) (the “Company”), a leading provider of cancer-focused genetic testing services [...]
Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
25/06/2018
BOSTON, June 25, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]

Pages